Back

Exploring the long-term effects of dapagliflozin in patients with stable acute myocardial infarction and preserved ejection fraction through a propensity score matching study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in coronary artery disease: from bench to bedside (2) Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Bu Yuan Hsiao

Taipei Medical University Hospital, Taipei (Taiwan)

6 More presentations in this session

Presentation thumbnail
Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II
Doctor T. Gu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Effects of rivaroxaban on vascular endothelial function and circulating endothelial progenitor cells: a randomized controlled trial
Ms M. Lin (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Restrictive versus liberal blood transfusion strategies in patients with myocardial infarction and anemia: individual patient data meta-analysis of randomized trials
Professor J. Carson (New Brunswick, US)
Abstract Slides Video
Presentation thumbnail
CSWT improves ventricular function by promoting angiogenesis through Rho/ROCK/ERK1/2 signal pathway in infarcted myocardium in rats
Professor Y. Wang (Kunming, CN)
Abstract Slides Video
Presentation thumbnail
Drug-coated balloon for de-novo coronary artery lesions exceeding 2.5 mm in diameter: optical coherence tomography analysis and clinical follow-up
Doctor L. Guo (Dalian, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in coronary artery disease: from bench to bedside (2)

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with primary anterior ST-elevation myocardial infarction initiated in early hospital period
thumbnail
Congress Presentation
The impact on CD146 congestion biomarker by early adding SGLT2i dapaglifozin to intravenous loop diuretic in patients with acute heart failure
thumbnail
Congress Presentation
Navigating the realms of SGLT2 inhibitors bridging clinical studies enthusiasm with practical realities

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources